indignation was palpable -particularly regarding the inclusion of genetic services. Who were they to speak for the experienced medical and clinical practitioners represented by their national and multinational professional societies around the world? We immediately considered how to counter this -and I sensed we were pushing at an open door. Maimon Cohen had previously discussed with me a need for coordination between the established 'continental' human genetics societies and had even thought of a snappy name 'COPS' -Committee of Presidents of (human genetic) Societies. The idea of an international federation had also been mooted. It was going to take a lot of work and commitment -would we in the ESHG take it on? We said yes, and that was essentially the end of the meeting. I suspect the fact that Vienna was in line for the 2001 International Congress of Human Genetics was influential in the ESHG being asked to launch the IFHGS, but as I recall, at the time, the question of the IFHGS taking over from the Permanent Committee was put on hold -one step at a time. There were many other factors at play and it was particularly valuable that Judy Hall was then president of the ASHG. She and Elaine Strass were extremely committed and helpful.
There were aspects in which I was less directly involved. I do not really know the chain of events that led to the IFHGS taking over from the Permanent Committee, but was aware of the 'fall out' that has been described elsewhere. 2 Ségolène Aymé was succeeding me as the president of the ESHG and with it, the 3-year term as the president of the new IFHGS dedicated to 'providing a transparent structure to facilitate communication throughout the international community of human geneticists'. Before working with Ségolène, Jean-Jacques and others on the draft IFHGS statutes, we had to find a structure that would function from the beginning. We essentially made pragmatic suggestions that built on the existing well-established (and funded) professional societies. We could not have a costly stand-alone organisation, and settled on the idea of the 'continental' societies being Full Members and individual national societies being Corresponding Members, for purely practical reasons. Full Members were few in number and their IFHGS representatives could be supported to travel to regular meetings. The initial Full Members were ASHG, ESHG and the Human Genetics Societies of Australasia (HGSA) through the good offices of Agnes Bankier and others. Working to encourage continental alliances, where these did not yet exist was, in my view, valuable in itself; and not just because one aim was to facilitate Full Membership of the IFHGS. It was part of getting to know the international community of human geneticists -and the different challenges we faced. The first additional Full Member was the Latin-American network society RELAGH (Red Latinoamericana de Genetica Humana) established in 2001 through the efforts of Dr Jose M Cantu (Mexico), Dr Roberto Giugliani (Brazil), Dr Alejandro Giraldo (Colombia) and others. This activity resulted in my having a memorable trip to Bogota to speak at the Fifth Colombian Genetics Congress in April 2002 at the invitation of Alejandro Giraldo. It was straight from the last talk of the day to the dance floor -the salsa or similar! But by this time, I had handed over the IFHGS liaison role to Jean-Jacques Cassiman.
What about those WHO guidelines? Fifteen WHO advisers from developed and developing nations met and revised the guidelines. The much shorter document (16 pages) was published in May 1998 as 'Proposed International Guidelines on the Ethical Issues on Medical Genetics and Genetic Services'. For the IFHGS and ESHG, the real legacy of the 'guideline saga' was that it encouraged Ségolène Aymé to seek EU funding for what was EUROGAPPP, through which she and others did excellent work over several years on various professional guidelines.
